Dechra Veterinary Products has enhanced its anaesthesia and analgesia portfolio with the introduction of Buprenodale.
Available in a 10ml multidose vial and is licensed for dogs, cats and horses, Buprenodale joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
Dechra’s Brand Manager Carol Morgan said: “The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK (GFK data, February 2014).
“The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse.”
- For more information on Dechra’s range of analgesics and anaesthetics, visit www.dechra.co.uk